Steve Rowland

TransCanada (Canada)

Papers

1

Total Citations

51

H-Index

1

About

Steve Rowland is a pioneering researcher in bioanalytical chemistry and pharmacokinetics, best known for advancing methods that reduce animal usage in drug development. His most-cited work, a 2001 study on serial bleeding of mice for pharmacokinetic studies, demonstrates his commitment to the 3Rs (Replacement, Reduction, and Refinement) in animal research. By integrating robotic sample preparation with fast liquid chromatography–mass spectrometry, Rowland enabled more efficient, high-throughput analysis from smaller blood volumes—a breakthrough that has been cited over 50 times. This work not only improved data quality in preclinical studies but also significantly lowered the number of animals required per experiment. Rowland’s contributions have had a lasting impact on pharmaceutical research, streamlining drug metabolism and pharmacokinetic (DMPK) workflows while promoting ethical standards. His innovative approach to combining automation and sensitive analytical techniques continues to influence modern bioanalysis, making him a key figure in the evolution of more humane and efficient drug testing practices.

Research Focus

Key Achievements

1
H-Index
1
Papers
51
Total Citations
51
Avg Citations/Paper
🏆 Most Cited Paper
Reduction of animal usage by serial bleeding of mice for pharmacokinetic studies: application of robotic sample preparation and fast liquid chromatography–mass spectrometry
51 citations · 2001
📈 Most Prolific Year: 2001 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: TransCanada (Canada)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago